NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

仿製藥:全球市場

Global Markets for Generic Drugs

出版商 BCC Research 商品編碼 1006811
出版日期 內容資訊 英文 155 Pages
訂單完成後即時交付
價格
仿製藥:全球市場 Global Markets for Generic Drugs
出版日期: 2021年05月19日內容資訊: 英文 155 Pages
簡介

全球仿製藥市場預計將從2020年的4116億美元增長到2025年的6503億美元。

此外,2020 年至 2025 年的複合年增長率預計為 9.6%。

本報告分析了全球仿製藥市場,分析了產品概況和基本市場結構、主要市場推動/制約因素、市場規模/增長率/市場份額趨勢展望,按地區/類型。詳細趨勢,近期臨床試驗(管道產品的開發)和資本交易的動向,主要公司的概況(總共20多家公司),以及新型冠狀病毒感染(COVID-19)的影響。我會提供它。

目錄

第 1 章介紹

第 2 章摘要亮點

第 3 章市場概覽

  • 簡介
  • 仿製藥行業的近期趨勢
  • 羅氏-波拉爾
  • 通用大廳
  • 非物質文化遺產

第 4 章冠狀病毒感染 (COVID-19) 的影響

  • 概述
  • 對製藥行業的短期影響
  • 對製藥行業的長期影響
  • COVID-19 對仿製藥市場的影響
  • 對供應鏈的影響

第 5 章新通用時代

  • 概述
  • 專利懸崖(Patent Cliff)
  • 仿製藥的種類
  • 簡單的泛型
  • 超級通用
  • 生物仿製藥
  • ANDA(簡單藥物批准申請)批准

第六章仿製藥市場的主要問題

  • 監管環境
  • 美國
  • 歐盟
  • 日本
  • 生物類似藥法規
  • 歐盟法規
  • 美國局勢的變化
  • 使用費
  • 主要製藥公司使用的防禦策略
  • 批准的仿製藥
  • 使用費
  • 仿製藥狀態變化
  • 歐洲情況
  • 專利和知識產權
  • 補充保護證書 (SPC)

第 7 章全球仿製藥市場

  • 全球藥品市場:品牌藥和仿製藥
  • 全球仿製藥市場
  • 按產品類別劃分的市場機會
  • 醫藥市場份額:按治療領域

第 8 章按地區劃分的市場細分

  • 簡介
  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太國家
  • 歐洲
  • 法國
  • 德國
  • 意大利
  • 英國
  • 西班牙
  • 其他歐洲國家
  • 其他國家 (RoW)

第九章行業趨勢

  • 競爭形勢
  • 市場趨勢
  • 仿製藥行業的結構
  • 近期併購(M&A)
  • 品牌藥公司的參與

第 10 章公司簡介

  • ASPEN HOLDINGS
  • CIPLA INC.
  • FRESENIUS KABI
  • LUPIN LTD.
  • MYLAN INC.
  • PFIZER INC.
  • SANDOZ INTERNATIONAL GMBH
  • SANOFI
  • SUN PHARMACEUTICAL INDUSTRIES LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.

第11章 其他國際企業

  • AUROBINDO PHARMALTD.
  • DR. REDDY'S LABORATORIESLTD.
  • EGIS PHARMACEUTICALS PLC
  • KRKA
  • PAR PHARMACEUTICALINC.
  • STADA ARZNEIMITTEL
  • STRIDES SHASUNLTD.
  • WOCKHARDTLTD.
  • ZYDUS CADILA

第12章 附錄:字典

目錄
Product Code: PHM009J

Highlights:

The global market for generic drugs should grow from $411.6 billion in 2020 to $650.3 billion by 2025, at compound annual growth rate (CAGR) of 9.6% for the period of 2020-2025.

The North American market for generic drugs should grow from $135.8 billion in 2020 to $224.1 billion by 2025, at a CAGR of 10.5% for the period of 2020-2025.

Asia-Pacific market for generic drugs should grow from $171.8 billion in 2020 to $289.6 billion by 2025, at a CAGR of 11.0% for the period of 2020-2025. 

Report Scope

This report discusses the implications of all the above-mentioned trends in the context of the current size and growth of the market for generic drugs, both in global terms and broken down by the most important national markets. The nature and structure of the generic drug industry is discussed, with profiles of the leading 20+ generic drug companies and an update on M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of the products involved.

Based on geography, the market has been segmented into North America, Europe, Asia-Pacific and Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data has been provided for the year 2019 as the base year, with forecasts for 2020 through 2025. The estimated values used are based on drug manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes

  • 38 tables
  • An updated review of the global market for generic drugs
  • Analyses of the global market trends, with data from 2018-2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Highlights of current and future market potential of generic drugs along with an emphasis on the major generics issue, regulatory landscape and patent cliff within the generic drugs industry
  • COVID-19 impact (both short term vs. long term) on the global generic drugs market compared to the overall pharmaceutical industry
  • Estimation of the market size and market forecast for pharmaceuticals and generic drugs by the most important geographies and major therapeutic categories of products
  • Key M&A deals, collaborations and partnerships, licensing and manufacturing agreements, and other investment strategies within this market
  • Competitive landscape of the key players in the global generic drugs market, analysis of company sales data, and structure of the generics industry
  • Insight into the pipeline analysis of new and generic drugs and their impact on the growth of the market
  • Company profiles of the leading players operating in global generic drugs market including Aspen, Cipla, Lupin, Pfizer, Sanofi, Sun Pharmaceuticals and Teva Pharmaceuticals

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Intended Audience
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Market Size and Evolution

Chapter 3 Market Overview

  • Introduction
  • Recent History of the Generic Drug Industry
  • Roche-Bolar
  • Generics Lobby
  • ICH

Chapter 4 Impact of COVID-19

  • Overview
  • Short-Term Impact on the Pharma Industry
  • Long-Term Impact on the Pharma Industry
  • Impact of COVID-19 on the Market for Generic Drugs
  • Impact on the Supply Chain

Chapter 5 The New Generics Era

  • Overview
  • The Patent Cliff
  • Types of Generic Drugs
  • Simple Generics
  • Super Generics
  • Biosimilars
  • ANDA (Abbreviated New Drug Application) Approvals

Chapter 6 Major Issues Within the Market for Generic Drugs

  • Regulatory Environment
  • U.S.
  • European Union
  • Japan
  • Regulation of Biosimilars
  • EU Provisions
  • Evolving Situation in the U.S.
  • User Fees
  • Defensive Strategies Used by Big Pharma
  • Authorized Generic Drugs
  • User Fees
  • Changing Climate for Generics
  • Situation in Europe
  • Patents and IP
  • Supplementary Protection Certificates

Chapter 7 Global Market for Generic Drugs

  • Global Pharmaceutical Market: Brand Name and Generic Drugs
  • Global Market for Generic Drugs
  • Market Opportunities by Product Class
  • Market Shares of Pharmaceutical Drugs by Therapeutic Area

Chapter 8 Market Breakdown by Region

  • Introduction
  • North America
  • U.S.
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
  • Europe
  • France
  • Germany
  • Italy
  • U.K.
  • Spain
  • Rest of Europe
  • Rest of the World

Chapter 9 Industry Trends

  • Competitive Landscape
  • Market Trends
  • Structure of the Generic Drug Industry
  • Recent Mergers and Acquisitions
  • Brand Name Company Involvement

Chapter 10 Company Profiles

  • ASPEN HOLDINGS
  • CIPLA INC.
  • FRESENIUS KABI
  • LUPIN LTD.
  • MYLAN INC.
  • PFIZER INC.
  • SANDOZ INTERNATIONAL GMBH
  • SANOFI
  • SUN PHARMACEUTICAL INDUSTRIES LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.

Chapter 11 Other International Companies

  • AUROBINDO PHARMA LTD.
  • DR. REDDY'S LABORATORIES LTD.
  • EGIS PHARMACEUTICALS PLC
  • KRKA
  • PAR PHARMACEUTICAL INC.
  • STADA ARZNEIMITTEL
  • STRIDES SHASUN LTD.
  • WOCKHARDT LTD.
  • ZYDUS CADILA

Chapter 12 Appendix: Terminology and Acronyms

List of Tables

  • Summary Table : Global Market for Generic Drugs, by Region, Through 2025
  • Table 1 : Global Market for Generic Drugs Compared with the Total Pharmaceutical Market, by Region, Through 2025
  • Table 2 : Coronavirus Reported Cases and Deaths, by Country, as of March 8, 2021
  • Table 3 : Major Recent and Upcoming Patent Expiries, 2016-2021
  • Table 4 : Sales of Brand Name Drugs Before and After Patent Expiry
  • Table 5 : Biologics with Recent or Upcoming Loss of Patent Protection
  • Table 6 : Recent Approvals of Biosimilars, 2018-2020
  • Table 7 : ANDA Approvals of Generic Drugs, by Company, 2019
  • Table 8 : Requirements for NDA and ANDA Applications
  • Table 9 : Global Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 10 : Global Market for Generic Drugs, by Top 10 Countries, Through 2025
  • Table 11 : Top 20 Generic Molecules, 2019
  • Table 12 : Global Top Selling Pharmaceuticals, 2019
  • Table 13 : Leading Anti-infective Products Sales, 2018
  • Table 14 : Leading CNS Products Sales, 2018
  • Table 15 : Leading Cardiovascular Product Sales, 2019
  • Table 16 : Leading Anti-arthritis Product Sales, 2018
  • Table 17 : Leading Respiratory Product Sales, 2018
  • Table 18 : Leading Anticancer Product Sales, 2018
  • Table 19 : U.S. Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 20 : Canadian Leading Therapeutic Classes in Retail and Hospital Purchases, 2019
  • Table 21 : Canadian Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 22 : Chinese Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 23 : Japanese Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 24 : Japanese Pharmaceutical Sales, by Top 25 Japanese Pharma Companies, 2018 and 2019
  • Table 25 : Indian Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 26 : Leading Generic Drug Companies in India
  • Table 27 : Rest of Asia-Pacific Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 28 : French Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 29 : German Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 30 : Italian Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 31 : U.K. Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 32 : Leading Pharma Companies in the U.K., by Company, 2018
  • Table 33 : Spanish Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 34 : Penetration of Generic Drugs in the Pharmaceutical Market in the Rest of Europe, by Country, 2019
  • Table 35 : Rest of European Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 36 : Rest of World Market for Generic Drugs Compared with the Total Pharmaceutical Market, Through 2025
  • Table 37 : Leading Generic Drug Companies, by Sales, 2019
  • Table 38 : Acronyms Used in This Report

List of Figures

  • Summary Figure : Global Market for Generic Drugs, by Region, 2018-2025
  • Figure 1 : Impact of COVID-19 on the Pharma Industry
  • Figure 2 : Trends in Global Prescription Drug Sales, 2015-2019
  • Figure 3 : Global Market Shares of Pharmaceutical Drugs, by Therapeutic Area, 2019
  • Figure 4 : Global Market Shares of Asthma Drugs, by Product Category, 2015
  • Figure 5 : Healthcare Expenditures in Major European Markets and the U.S., 2019